STAT

"I’m a MAHA activist. I went into the public health lion’s den — and it changed how I think. Public health is not the enemy. The system is." trib.al/bviV5Xj

Once-divisive ‘exon-skipping’ treatments for Duchenne muscular dystrophy are showing startling promise trib.al/uHTxWSp

RFK Jr.'s apparent contradiction on vaccines and peptides reflects a deeper belief: Americans have a right to try and can choose their own risks. trib.al/JHfXwYm

Trump promised to clamp down on health insurers. His policies are enriching them trib.al/FpHICXD

GAO report shows gap between scale of illegal vapes and enforcement. Anti-smoking advocates call for more vigorous action by the Justice Department. trib.al/FHVS3MX

Top health officials highlight efforts to make medical records more portable. While tech companies and CMS celebrate, questions linger about effectiveness of voluntary pledge. trib.al/E2pPct5

Sports betting is creating a twofold public health crisis for some young men. Addressing the problems is harder than it may sound. trib.al/K8I2dlC

A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval. trib.al/RPDc7My

“Even if not everybody is losing a ton of money right now, you're creating this culture of large numbers of gamblers,” Isaac Rose-Berman says on the First Opinion Podcast. trib.al/fUNExyI

“Is ‘lack of education’ really what we think the problem is in prevention care?” a STAT reader asks. trib.al/qXcpI4P

Replimune $REPL skin cancer drug that became FDA flashpoint is rejected again statnews.com/2026/04/10/ski… via @Jasonmmast

And more pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletter trib.al/kXlFKYM

GAO report shows gap between scale of illegal vapes and enforcement . Anti-smoking advocates call for more vigorous action by the Justice Department. trib.al/tgrHjgJ

Replimune skin cancer drug that became FDA flashpoint is rejected again trib.al/o93QytW

A revised ACIP charter, sports betting and gambling addiction, and other health news from Morning Rounds trib.al/yzzcseN

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. trib.al/kutznU9

The Justice Department's actions on illegal vapes pales next to the scale of the problem, anti-smoking advocates say. trib.al/JzGoa5l

A cancer drug candidate that, rightly or wrongly, became a flashpoint at FDA, fails on a second try at approval. trib.al/EsopAVC

CAR-T promise in autoimmunity, GSK's goodbye to leucovorin, and more biotech news trib.al/fdIIi55

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now, it's being disrupted: trib.al/kDz2128